M&A - IVY FUNDS

Form Type: N-14/A

Filing Date: 2025-03-24

Corporate Action: Merger

Type: New

Accession Number: 000206159025000019

Filing Summary: The document outlines the reorganization of the Macquarie Multi-Asset Income Fund (the Acquired Fund) into the Macquarie Balanced Fund (the Acquiring Fund) scheduled to occur on or about April 25, 2025. The reorganization will involve all assets from the Acquired Fund being transferred to the Acquiring Fund, with shareholders receiving shares of equal aggregate net asset value in the new fund. The Board of Trustees approved the plan, concluding the reorganization is in the shareholders' best interest and that it will not dilute their existing interests. Following the merger, the Acquired Fund will be liquidated and dissolved, while shareholders will automatically have their shares converted without the need for any action or votes. The document emphasizes that the investment objectives and strategies of both funds share key similarities despite some differences. It further notes the tax-free nature of the merger and how it aligns with the overall strategy of enhancing economies of scale.

Document Link: View Document

Form Type: N-14/A

Filing Date: 2025-03-24

Corporate Action: Merger

Type: New

Accession Number: 000206159025000020

Filing Summary: This Proxy Statement/Prospectus is being provided to solicit votes for a proposed Reorganization of the Macquarie Global Allocation Fund (Acquired Fund) into the Macquarie Balanced Fund (Acquiring Fund). The Board of Trustees has unanimously approved the Reorganization and recommends that shareholders vote in favor of the proposal. The Meeting is scheduled for May 6, 2025, where shareholders will approve the Plan, which entails the acquisition of assets of the Acquired Fund in exchange for shares of the Acquiring Fund, along with the complete liquidation of the Acquired Fund. If the proposal is approved, shareholders will receive shares of the Acquiring Fund equivalent in value to their shares of the Acquired Fund on the anticipated Reorganization Date of June 27, 2025. The overall costs of the Reorganization are estimated to be between $334,277 and $415,630. Should the Reorganization fail to receive approval, the Acquired Fund will continue its operations. Shareholders are encouraged to vote to avoid additional solicitation costs and ensure their votes are counted. The Reorganization is intended to be tax-free for federal income tax purposes, and shareholders are advised to consult their tax advisors regarding any potential tax liabilities related to distributions.

Document Link: View Document

Form Type: 497

Filing Date: 2025-03-18

Corporate Action: Merger

Type: New

Accession Number: 000113743925000223

Filing Summary: On February 11-13, 2025, the Board of Trustees of Ivy Funds approved the reorganization of the Macquarie Global Allocation Fund into the Macquarie Balanced Fund, a series of Ivy Funds, subject to shareholder approval. The reorganization is anticipated to occur on or about June 27, 2025, at which time the Fund will close to new investors and existing shareholders. Prior to the reorganization, all income and gains not previously distributed will be distributed to shareholders. It is advised that investors consult with tax professionals regarding the tax implications of this reorganization.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-03-18

Corporate Action: Merger

Type: Update

Accession Number: 000113743925000225

Filing Summary: On February 11-13, 2025, the Board of Trustees of Ivy Funds approved the reorganization (Reorganization) of the Macquarie Global Allocation Fund into and with a substantially similar fund and class of Macquarie Balanced Fund. The Reorganization is expected to take place on or about June 27, 2025, subject to shareholder approval. Effective one week prior to the Reorganization Date, the Fund will close to new investors and existing shareholders. The Fund will distribute its income and gains to shareholders before the Reorganization Date. Investors should consult tax professionals regarding the potential tax implications of their investments and distributions.

Document Link: View Document

Form Type: 497

Filing Date: 2025-02-13

Corporate Action: Merger

Type: New

Accession Number: 000113743925000063

Filing Summary: On February 11-13, 2025, the Board of Trustees of Ivy Funds approved an Agreement and Plan of Reorganization between the Macquarie Multi-Asset Income Fund (the Acquired Fund) and the Macquarie Balanced Fund (the Acquiring Fund). The reorganization involves the acquisition of all assets and liabilities of the Acquired Fund in exchange for shares of the Acquiring Fund, followed by the liquidation and termination of the Acquired Fund. Shareholders of the Acquired Fund will receive an information statement/prospectus in late March 2025 regarding the Reorganization, expected to take place around April 25, 2025. There will be a waiver of contingent deferred sales charges on redemptions from the Acquired Fund, effective 10 business days from this Supplement’s date. The Acquired Fund will close to purchases and exchanges one week prior to the Reorganization Date, although reinvested dividends and automatic purchases may continue until that date. Shareholders will also receive a distribution of all income and gains prior to the Reorganization Date.

Document Link: View Document

Form Type: 497

Filing Date: 2025-02-13

Corporate Action: Merger

Type: New

Accession Number: 000113743925000064

Filing Summary: On February 11-13, 2025, the Boards of Trustees of Ivy Funds and Voyageur Insured Funds approved an Agreement and Plan of Reorganization, which entails the merger of Acquired Funds into their corresponding Acquiring Funds. Specifically, the Macquarie Global Allocation Fund will merge into the Macquarie Balanced Fund, and the Macquarie Tax-Free Arizona Fund will merge into the Macquarie Tax-Free USA Fund. The Agreement includes provisions for the acquisition of all assets and liabilities of the Acquired Funds by the Acquiring Funds in exchange for shares. Shareholders of the Acquired Funds will need to approve the Agreement, with a special meeting scheduled for May 6, 2025. If approved, the Reorganizations are expected to take place around June 6, 2025. The Supplement highlights the costs will be borne by the Funds and the management company, and details regarding the Reorganizations will be provided in a forthcoming proxy statement/prospectus expected in late March 2025. The document emphasizes that no shareholder action is needed at this time and includes tax considerations for investors.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-02-13

Corporate Action: Merger

Type: New

Accession Number: 000113743925000065

Filing Summary: On February 11-13, 2025, the Boards of Trustees of Ivy Funds approved an Agreement and Plan of Reorganization between each Fund (Acquired Fund) and the corresponding Acquiring Fund. This involves the acquisition of all assets and liabilities of each Acquired Fund by the corresponding Acquiring Fund in exchange for shares. The Agreement outlines the plan for shareholders to receive shares of the Acquiring Fund, with a subsequent liquidation and termination of each Acquired Fund. Shareholders' approval is required and a vote is anticipated on May 6, 2025. If approved, the mergers are expected to occur around June 6, 2025, although this date may change. Costs associated with the Reorganizations will be borne by both Funds and Delaware Management Company. A forthcoming proxy statement/prospectus will provide more detailed information. Effective 10 business days from the Supplement date, deferred sales charges will be waived on redemptions from the Acquired Funds until the Reorganization Date. Each Acquired Fund will close to new purchases one week before the Reorganization Date, while existing shareholders may continue certain transactions until then. The document advises consulting a tax professional regarding tax implications of investments and distributions.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-02-13

Corporate Action: Merger

Type: New

Accession Number: 000113743925000066

Filing Summary: On February 11-13, 2025, the Board of Trustees of Ivy Funds approved an Agreement and Plan of Reorganization between the Macquarie Multi-Asset Income Fund (the Acquired Fund) and the Macquarie Balanced Fund (the Acquiring Fund). The Agreement entails the acquisition of all assets and assumption of all liabilities of the Acquired Fund by the Acquiring Fund in exchange for shares of the Acquiring Fund, resulting in the reorganization of the Acquired Fund into the Acquiring Fund. The shareholders of the Acquired Fund will receive shares of the Acquiring Fund and the Acquired Fund will be liquidated and terminated. The reorganization is expected to be finalized on or about April 25, 2025, although it may occur sooner or later depending on various circumstances. Shareholders of the Acquired Fund are to receive an information statement/prospectus in late March 2025 providing details about the reorganization. The Acquired Fund will waive contingent deferred sales charges on redemptions 10 business days from this Supplement's date and will close to purchases and exchanges one week before the Reorganization Date. Prior to the closing of the reorganization, the Acquired Fund is required to distribute any undistributed income and gains to its shareholders for the taxable years ending on or before the Reorganization Date.

Document Link: View Document

Form Type: N-14

Filing Date: 2025-02-13

Corporate Action: Merger

Type: New

Accession Number: 000113743925000080

Filing Summary: On February 13, 2025, the Board of Trustees of Ivy Funds approved the Reorganization of Macquarie Multi-Asset Income Fund (the Acquired Fund) into Macquarie Balanced Fund (the Acquiring Fund), scheduled for April 25, 2025. This process involves the exchange of shares without the requirement of shareholder votes. The Reorganization is deemed to be in the best interest of shareholders, as both funds have similar investment objectives and management teams, with expected lower expense ratios for the Acquiring Fund post-Reorganization. Shareholders will not incur sales charges for exchanging their shares prior to this event, and the Reorganization is structured to qualify as a tax-free transaction. Further details regarding the assets, management expectations, and potential risks and benefits of the funds involved are outlined in the Information Statement/Prospectus, and shareholders are encouraged to review the full documentation for comprehensive insights.

Document Link: View Document

Form Type: N-14

Filing Date: 2025-02-13

Corporate Action: Merger

Type: New

Accession Number: 000113743925000082

Filing Summary: Ivy Funds filed a registration statement for a proposed merger between Macquarie Global Allocation Fund (the 'Acquired Fund') and Macquarie Balanced Fund (the 'Acquiring Fund'). This merger is intended to consolidate the Acquired Fund into the Acquiring Fund, which is expected to take place on or about June 6, 2025, following a Special Meeting of Shareholders scheduled for May 6, 2025. The proposal is backed by the Board of Trustees of Ivy Funds, which unanimously approved the Agreement and Plan of Reorganization. Shareholders will vote on whether to approve this plan, which entails the Acquiring Fund acquiring substantially all assets of the Acquired Fund in exchange for shares of the Acquiring Fund, followed by the complete liquidation of the Acquired Fund. Key motivations for the merger include aligning investment objectives, leveraging economies of scale, and a favorable comparison of fund performance. Shareholders retaining their rights will receive shares of the Acquiring Fund corresponding to their shares of the Acquired Fund, with no additional sales charges for certain classes of shares.

Document Link: View Document